本页汇总 龙胆草** 的 5 篇安全性公开文献，按毒性终点分区，逐条标注研究类型、物种、染毒途径与来源。以上均为各原研究/评估机构的结论，本平台不作再评价，也不构成对该成分的安全性判定。
0.5% MRC显著降低SLS引起的皮肤刺激，表明其具有抗刺激作用，而非刺激风险
0.5% MRC significantly reduced SLS-induced skin irritation, indicating an anti-irritative effect rather than irritation risk
未观察到皮肤刺激或其他全身副作用，表明龙胆紫在0.1%浓度下无皮肤刺激风险
No skin irritation or systemic side effects were observed, indicating gentian violet at 0.1% concentration has no skin irritation risk
报告一例因自行滴入1%龙胆紫水溶液导致双侧角结膜炎，并继发葡萄膜炎和革兰阴性结膜炎，证实龙胆紫对眼表有毒性，可引起严重眼内炎症。
Reports a case of bilateral keratoconjunctivitis caused by self-instillation of 1% aqueous gentian violet, complicated by secondary uveitis and gram-negative conjunctivitis, confirming that gentian violet is toxic to ocular surfaces and can cause severe intraocular inflammation.
患者对标记溶液过敏，但单独测试龙胆紫（gentian violet）成分结果为阴性，表明龙胆紫本身无致敏风险。
Patient allergic to marker solution, but patch test with gentian violet alone was negative, indicating no sensitization risk from gentian violet.
摘要显示龙胆紫（gentian violet）在MET1细胞中IC50低于30 μM，且光毒性实验表明其具有光敏化活性，证实存在光毒性风险。
The abstract shows that gentian violet has IC50 <30 μM in MET1 cells and phototoxicity assays indicate photosensitizing activity, confirming phototoxic risk.
毒理学实验记录来自标准化的毒性试验（如 OECD 导则试验），给出的是剂量/浓度层面的实验值；公开文献是研究者围绕化妆品实际使用场景发表的研究（本页 5 篇），结论均为原作者观点。两类证据并列呈现，本平台不做合并判定。
目前暂无收录含龙胆草**的市售原料。如果贵司供应该原料，欢迎入驻 INCILABS 原料库——您的产品将出现在本页及相关成分页，直接触达正在检索该成分的配方研发人员。